Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Fine microstructure formation in steel under ultrafast heating.
Yonemura M, Nishibata H, Nishiura T, Ooura N, Yoshimoto Y, Fujiwara K, Kawano K, Terai T, Inubushi Y, Inoue I, Tono K, Yabashi M. Yonemura M, et al. Sci Rep. 2019 Aug 2;9(1):11241. doi: 10.1038/s41598-019-47668-6. Sci Rep. 2019. PMID: 31375725 Free PMC article.
Fine microstructure formation in steel under ultrafast heating and cooling.
Yonemura M, Nishibata H, Fujimura R, Ooura N, Hata K, Fujiwara K, Kawano K, Yamaguchi I, Terai T, Inubushi Y, Inoue I, Yabuuchi T, Tono K, Yabashi M. Yonemura M, et al. Sci Rep. 2022 Feb 9;12(1):2237. doi: 10.1038/s41598-022-06280-x. Sci Rep. 2022. PMID: 35140299 Free PMC article.
Transarterial embolization of renal arteriovenous malformations: treatment outcomes according to angiographic classification.
Hayashi H, Kiyosue H, Tamura Y, Ueda H, Yonemura M, Sasaki G, Hokamura M, Ishiuchi S, Kanaya H, Uetani H, Oda S, Kawanaka K, Hirai T. Hayashi H, et al. Among authors: yonemura m. J Vasc Interv Radiol. 2024 Mar 25:S1051-0443(24)00246-X. doi: 10.1016/j.jvir.2024.03.024. Online ahead of print. J Vasc Interv Radiol. 2024. PMID: 38537737
Clinical and biomarker factors affecting survival in patients with platinum-sensitive relapsed ovarian cancer receiving olaparib monotherapy: a multicenter retrospective study.
Tashiro R, Kawazoe H, Mamishin K, Seto K, Udagawa R, Saito Y, Hashimoto H, Shimoi T, Yonemori K, Yonemura M, Terakado H, Nishimura T, Kawasaki T, Furukawa T, Nakamura T. Tashiro R, et al. Among authors: yonemura m. Sci Rep. 2023 Jul 24;13(1):11962. doi: 10.1038/s41598-023-39224-0. Sci Rep. 2023. PMID: 37488223 Free PMC article.
Patient-associated risk factors for severe anemia in patients with advanced ovarian or breast cancer receiving olaparib monotherapy: A multicenter retrospective study.
Tashiro R, Kawazoe H, Mamishin K, Seto K, Udagawa R, Saito Y, Hashimoto H, Shimoi T, Yonemori K, Yonemura M, Terakado H, Kawasaki T, Furukawa T, Nakamura T. Tashiro R, et al. Among authors: yonemura m. Front Oncol. 2022 Oct 4;12:898150. doi: 10.3389/fonc.2022.898150. eCollection 2022. Front Oncol. 2022. PMID: 36267984 Free PMC article.
Unexpectedly Large Contribution of Oxygen to Charge Compensation Triggered by Structural Disordering: Detailed Experimental and Theoretical Study on a Li3NbO4-NiO Binary System.
Fukuma R, Harada M, Zhao W, Sawamura M, Noda Y, Nakayama M, Goto M, Kan D, Shimakawa Y, Yonemura M, Ikeda N, Watanuki R, Andersen HL, D'Angelo AM, Sharma N, Park J, Byon HR, Fukuyama S, Han Z, Fukumitsu H, Schulz-Dobrick M, Yamanaka K, Yamagishi H, Ohta T, Yabuuchi N. Fukuma R, et al. Among authors: yonemura m. ACS Cent Sci. 2022 Jun 22;8(6):775-794. doi: 10.1021/acscentsci.2c00238. Epub 2022 May 23. ACS Cent Sci. 2022. PMID: 35756387 Free PMC article.
73 results